Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative

Lung, Respiratory and Thoracic Cancer

Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

Lung Cancer

Sugisaka J, Fujimoto D, Tamiya M, Hata A, Matsumoto H, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Kijima T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Saito G, Miura S, Yamaguchi T, Daga H, Sakata S, Yamamoto N, Akamatsu H

doi: 10.1016/j.lungcan.2024.108056

Lung, Respiratory and Thoracic Cancer

Brief Report: Should a prior cancer history be reevaluated as an exclusion for clinical trial participation?

Lung Cancer

Ayoade O, Canavan ME, Caturegli G, Boffa DJ

doi: 10.1016/j.lungcan.2024.108032

Breast Cancer

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial

J Natl Cancer Inst

Johansson A, Dar H, Nordenskjöld A, Perez-Tenorio G, Tobin NP, Yau C, Benz CC, Esserman LJ, van 't Veer LJ, Nordenskjöld B, Stål O, Fornander T, Lindström LS

doi: 10.1093/jnci/djae268

Gastrointestinal Cancer

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

J Clin Oncol

Takashima A, Hamaguchi T, Mizusawa J, Nagashima F, Ando M, Ojima H, Denda T, Watanabe J, Shinozaki K, Baba H, Asayama M, Hasegawa S, Masuishi T, Nakata K, Tsukamoto S, Katayama H, Nakamura K, Fukuda H, Kanemitsu Y, Shimada Y, Colorectal Cancer Study Group in Japan Clinical Oncology Group (JCOG)

doi: 10.1200/JCO.23.02722

Lung, Respiratory and Thoracic Cancer

Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis

Lung Cancer

Aptekar J, Jain R, Korytowsky B, Shafquat A, Hendershot J, Talwai A, Itzkovich Y, Padda SK

doi: 10.1016/j.lungcan.2024.107854

Gastrointestinal Cancer

Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

Eur J Cancer

Kamp D, May AM, Adenis A, Capela A, Derks S, De Felice F, Dovnik NF, Hierro C, Ilhan-Mutlu A, Lordick F, Obermannova RL, Petrillo A, Puccini A, Raimundo A, Roviello G, Siebenhüner A, Slingerland M, Smyth EC, van Laarhoven HWM, Mohammad NH

doi: 10.1016/j.ejca.2025.115278

Gastrointestinal Cancer

Associations between degree of food processing and colorectal cancer risk in a large-scale European cohort

Int J Cancer

Al Nahas A, Yammine Ghantous S, Morales Berstein F, Cakmak EK, Biessy C, Nicolas G, Kliemann N, Lopez JB, Jacobs I, Gonzalez-Gil EM, Cairat M, Pinho MGM, Bertazzi Levy R, Rauber F, Vamos EP, Chang K, Millett C, Touvier M, Kesse-Guyot E, Severi G, Marques C, Hajji M, Macciotta A, Masala G, Fordellone M, Agnoli C, Amiano P, Guevara M, Tjønneland A, Kyrø C, Derksen JWG, Smit KC, Schulze MB, Jannasch F, Kaaks R, Katzke V, Braaten T, Brustad M, Skeie G, Harewood R, Heath A, Vineis P, Weiderpass E, Ferrari P, Gunter MJ, Huybrechts I

doi: 10.1002/ijc.35361

Gastrointestinal Cancer

First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial

JAMA Oncol

Bond MJG, Bolhuis K, Loosveld OJL, de Groot JWB, Droogendijk H, Helgason HH, Hendriks MP, Klaase JM, Kazemier G, Liem MSL, Rijken AM, Verhoef C, de Wilt JHW, de Jong KP, Gerhards MF, van Amerongen MJ, Engelbrecht MRW, van Lienden KP, Hermans JJ, Molenaar IQ, Grünhagen DJ, de Valk B, Haberkorn BCM, Kerver ED, Erdkamp F, van Alphen RJ, Mathijssen-van Stein D, Komurcu A, May AM, Swijnenburg RJ, Punt CJA, Dutch Colorectal Cancer Group

doi: 10.1001/jamaoncol.2024.5174

Genitourinary Cancer

Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial

Eur Urol

Kishan AU, Lamb JM, Wilhalme H, Casado M, Chong N, Zello L, Juarez JE, Jiang T, Neilsen BK, Low DA, Yang Y, Neylon J, Basehart V, Martin Ma T, Valle LF, Cao M, Steinberg ML

doi: 10.1016/j.eururo.2024.10.026

Related content

Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

Brief Report: Should a prior cancer history be reevaluated as an exclusion for clinical trial participation?

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)

Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis

Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

Associations between degree of food processing and colorectal cancer risk in a large-scale European cohort

First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial

Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial